We report for the first time that CD16 surface levels on total exosomes, but not on CD44v3(+) TEX, correlate with clinicopathological variables in HNSCC patients and could therefore be considered as liquid biomarkers for tumor status and aggressiveness. This evidence concerns the gene FCGR3A and neoplasm.